The prognostic utility of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease: The largest cohort to date
AA Kolkailah, M Iskander, F Iskander, PP Patel… - Journal of Nuclear …, 2022 - Elsevier
Background There are limited data on the prognostic utility of regadenoson SPECT
myocardial perfusion imaging (MPI) in patients with end-stage renal disease (ESRD).
Methods and Results In a single-center, retrospective study, we analyzed consecutive ESRD
patients who underwent regadenoson SPECT-MPI. The severity of MPI abnormalities and
ischemic burden were determined quantitatively. The primary endpoint was major adverse
cardiac events (MACE), defined as the composite of cardiac death or myocardial infarction …
myocardial perfusion imaging (MPI) in patients with end-stage renal disease (ESRD).
Methods and Results In a single-center, retrospective study, we analyzed consecutive ESRD
patients who underwent regadenoson SPECT-MPI. The severity of MPI abnormalities and
ischemic burden were determined quantitatively. The primary endpoint was major adverse
cardiac events (MACE), defined as the composite of cardiac death or myocardial infarction …
以上显示的是最相近的搜索结果。 查看全部搜索结果